INmune Bio Inc
NASDAQ:INMB

Watchlist Manager
INmune Bio Inc Logo
INmune Bio Inc
NASDAQ:INMB
Watchlist
Price: 1.64 USD -3.53% Market Closed
Market Cap: $43.6m

Wall Street
Price Targets

INMB Price Targets Summary
INmune Bio Inc

Wall Street analysts forecast INMB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INMB is 5.36 USD with a low forecast of 2.02 USD and a high forecast of 8.4 USD.

Lowest
Price Target
2.02 USD
23% Upside
Average
Price Target
5.36 USD
227% Upside
Highest
Price Target
8.4 USD
412% Upside
INmune Bio Inc Competitors:
Price Targets
PTGX
Protagonist Therapeutics Inc
17% Upside
CENT
Central Garden & Pet Co
36% Upside
CFFN
Capitol Federal Financial Inc
2% Upside

Revenue
Forecast

N/A
Past Growth
589% / Year
Estimated Growth
Estimates Accuracy
31%
Average Beat
N/A
Past Growth
589% / Year
Estimated Growth
Estimates Accuracy
31%
Average Beat

The compound annual growth rate of INmune Bio Inc's revenue for the next 4 years is 589%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-40%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-40%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INMB's stock price target?
Price Target
5.36 USD

According to Wall Street analysts, the average 1-year price target for INMB is 5.36 USD with a low forecast of 2.02 USD and a high forecast of 8.4 USD.

What is INmune Bio Inc's Revenue forecast?
Projected CAGR
589%

The compound annual growth rate of INmune Bio Inc's revenue for the next 4 years is 589%.

Back to Top